polatuzumab vedotin
roche
[' pola ', 'polatuzumab', 'lymphoma', 'lymsm']
congress | #ash22 discussed early progression in pts with lbcl after car-t therapy. salvage therapies produced a higher response than chemotherapy. polatuzumab regimens yielded the highest response rates. #lymsm #medicalcongress #hematology 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm